CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 635 enrolled
Drug / intervention
RDDTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01416857
NCT01416857N/ACompleted

ED Disability Diagnostic Tool: a Health Information Technology Feasibility Study

Yale University·interventional·Posted Aug 15, 2011·Updated Jul 9, 2014

In Brief

A clinical study evaluating RDDT for Disability Diagnosis. Completed, enrolled 635 participants across 2 sites.

Detailed Summary

Aim 1: To develop and validate an Emergency Department(ED) Rasch Disability Diagnostic Tool (RDDT). Hypothesis: * Rasch modeling will provide an instrument with better measurement properties, including increased reliability and validity compared to currently available ED measure of disability (MOD). Aim 2: To conduct a randomized controlled trial to evaluate the utility of the ED-RDDT to reduce rehospitalizations in Medicare recipients visiting an urban Emergency Department for non-traumatic illness Hypotheses: * Compared to the standard screening tool, the ED RDDT will reduce reutilization of the hospital (ED visits, hospital admissions, or death) within 60 days of discharge. * The ED RDDT will reduce costs to Medicare, hospitals and patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 15, 2011
Enrollment StartAug 1, 2011
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 14.9 years ago

Interventions

RDDTother